US 12,440,454 B2
Pharmaceutical compositions containing hemp extract for administration to felines and related methods
Christian Kjaer, South Portland, ME (US); and German Graff, South Portland, ME (US)
Assigned to Portland Technology Holdings LLC, South Portland, ME (US)
Filed by Portland Technology Holdings LLC, South Portland, ME (US)
Filed on Feb. 1, 2023, as Appl. No. 18/162,990.
Claims priority of provisional application 63/267,417, filed on Feb. 1, 2022.
Prior Publication US 2023/0285318 A1, Sep. 14, 2023
Int. Cl. A61K 31/05 (2006.01); A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61K 31/352 (2006.01)
CPC A61K 31/05 (2013.01) [A61K 9/0056 (2013.01); A61K 31/192 (2013.01); A61K 31/352 (2013.01)] 18 Claims
 
1. A pharmaceutical composition comprising hemp extract, wherein the pharmaceutical composition is formulated in an orally deliverable paste for oral administration and wherein the paste comprises 1-10 mg of cannabidiol per g of paste, 1-10 mg of cannabidiolic acid per g of paste, 0.01-1 mg of cannabigerol per g of paste, and 0.01-1 mg of cannabigerolic acid per g of paste.